Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|May 16, 2016
Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activityWensheng Yu, Craig A Coburn, De-Yi Yang, et al.Bioorganic & Medicinal Chemistry Letters|July 18, 2016
Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitorsMichael P Dwyer, Kerry M Keertikar, Lei Chen, et al.Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Discovery of potent macrocyclic HCV NS5A inhibitorsWensheng Yu, Bancha Vibulbhan, Stuart B Rosenblum, et al.Bioorganic & Medicinal Chemistry Letters|September 30, 2016
Structure-activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.Bioorganic & Medicinal Chemistry Letters|August 29, 2016
Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Guowei Zhou, Craig A Coburn, et al.Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Alkyl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.Journal of Medicinal Chemistry|November 4, 2016
Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated PolymorphismsLing Tong, Wensheng Yu, Lei Chen, et al.Bioorganic & Medicinal Chemistry Letters|October 2, 2007
Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2Kamil Paruch, Michael P Dwyer, Carmen Alvarez, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent KinasesKamil Paruch, Michael P Dwyer, Carmen Alvarez, et al.Bioorganic & Medicinal Chemistry Letters|February 7, 2016
Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR developmentAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.Pageof 4